We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




FujiFilm and Dotmatics Partner to Develop Research Data Visualization Solutions

By LabMedica International staff writers
Posted on 26 Aug 2009
Research informatics company Dotmatics, Ltd. More...
(Bishop's Stortford, UK) has been selected by FujiFilm Imaging Colorants, Ltd. (FujiFilm; Tokyo, Japan) to provide data visualization solutions (Vortex) for their research teams. Dotmatics Vortex was selected to facilitate all the research data visualization required by FujiFilm. Dotmatics and FujiFilm have entered into a strategic relationship to develop Vortex further.

Paul Wight, research associate at FujiFilm said, "We are very happy to be working with Dotmatics who provided an excellent and responsive service throughout our evaluation. A key point for us in product and service purchases is flexibility and Dotmatics proved extremely helpful in the way they sell and service their offering, making the selection decision an easy one.”

Steve Gallagher, CEO at Dotmatics, said, "We are pleased to be working with FujiFilm and providing Vortex to meet all their data visualization needs. We look forward to developing Vortex with FujiFilm to keep up-to-date with their innovative research requirements.”

Dotmatics' Vortex has the following advantages: Chemically aware out of the box, including structure depiction and searching; easy to customize with Python scripting; superior quality charting and analysis; import files (i.e., sdf, xls, CSV) or pull data from databases and web services; support for Windows, Mac, and Linux; and direct export to Microsoft PowerPoint.

Dotmatics is a scientific software company deploying web-based knowledge solutions that dramatically improve the way scientific data is queried, browsed, managed, shared, and visualized within companies. Dotmatics has significant expertise in cheminformatics techniques including chemical databases, structure-activity relationships (SAR) analysis, data management, and data visualization.

The Dotmatics suite includes Browser--a query and visualization tool for biologic and chemical datasets; Pinpoint--an Oracle cartridge allowing rapid indexing and searching of chemical databases; Gateway--a centralized depot for sharing information with colleagues and external collaborators; Nucleus--a web-based tool for importing, mapping, and storing data from existing sources; Register--a web-based tool for single and batch compound registration; and Vortex--an advanced visualization and analytics tool for scientific and nonscientific data. Pinpoint is developed in collaboration with Astex Therapeutics, Ltd. (Cambridge, UK).

Related Links:

Dotmatics
Fujifilm


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.